Patient age, histologic features, and length of survival in patients with glioblastoma multiforme
- PMID: 3030531
- DOI: 10.1002/1097-0142(19870501)59:9<1617::aid-cncr2820590916>3.0.co;2-x
Patient age, histologic features, and length of survival in patients with glioblastoma multiforme
Abstract
Histologic sections from 71 patients with glioblastoma multiforme were reviewed to identify histologic prognostic factors and to explain the significantly shorter survival in older patients. Slides were studied for 14 histologic variables from a group of 35 patients aged less 45 years and from 36 patients aged 65 years or more. The relation of these histologic factors to the length of survival and age group was then investigated. The results document the marked histologic and cytologic heterogeneity of the glioblastoma and reaffirm the importance of necrosis as a prognostic factor. The results further suggest that patients whose glioblastomas contained microcysts, pseudopalisading, cells with astrocytic differentiation, and large areas of better differentiated glioma, did better than those patients whose lesions were homogeneously composed of small cells or whose lesion had a small median nuclear size. The study reaffirmed the strong (P less than 0.0001) negative relationship between advancing age and duration of postoperative survival. The presence of necrosis, a smaller standard deviation of nuclear size, the extent of vascular proliferation, the absence of well differentiated neoplastic fibrillary astrocytes, and neoplasms composed homogeneously of small cells were related to patient age and offered a possible explanation for at least part of the observed age effect. However, the strong relation between age and survival remained significant when adjusted for other variables, and the effect of age must rest largely on factors other than those detected in this morphologic study.
Similar articles
-
Correlation among pathology, genotype, and patient outcomes in glioblastoma.J Neuropathol Exp Neurol. 2006 Sep;65(9):846-54. doi: 10.1097/01.jnen.0000235118.75182.94. J Neuropathol Exp Neurol. 2006. PMID: 16957578
-
Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications.Cancer. 1985 Sep 1;56(5):1106-11. doi: 10.1002/1097-0142(19850901)56:5<1106::aid-cncr2820560525>3.0.co;2-2. Cancer. 1985. PMID: 2990664
-
Cytologic composition of the untreated glioblastoma with implications for evaluation of needle biopsies.Cancer. 1989 May 15;63(10):2014-23. doi: 10.1002/1097-0142(19890515)63:10<2014::aid-cncr2820631025>3.0.co;2-l. Cancer. 1989. PMID: 2539242
-
Pathologic analysis of primary brain tumors.Neurol Clin. 1985 Nov;3(4):711-28. Neurol Clin. 1985. PMID: 3001488 Review.
-
Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.Drug Resist Updat. 2015 Mar;19:1-12. doi: 10.1016/j.drup.2015.02.002. Epub 2015 Mar 6. Drug Resist Updat. 2015. PMID: 25791797 Review.
Cited by
-
Clinicopathological evaluation of 78 astrocytomas in Taiwan with emphasis on a simple grading system.J Neurooncol. 1992 Jul;13(3):265-76. doi: 10.1007/BF00172480. J Neurooncol. 1992. PMID: 1325543
-
Targeted molecular therapy for malignant gliomas.Curr Treat Options Oncol. 2004 Dec;5(6):519-26. doi: 10.1007/s11864-004-0040-4. Curr Treat Options Oncol. 2004. PMID: 15509485 Review.
-
MR imaging correlates of survival in patients with high-grade gliomas.AJNR Am J Neuroradiol. 2005 Nov-Dec;26(10):2466-74. AJNR Am J Neuroradiol. 2005. PMID: 16286386 Free PMC article.
-
Multivariate analysis of clinical prognostic factors in patients with glioblastoma multiforme treated with a combined modality approach.J Cancer Res Clin Oncol. 2003 Aug;129(8):477-84. doi: 10.1007/s00432-003-0471-5. Epub 2003 Jul 15. J Cancer Res Clin Oncol. 2003. PMID: 12884028
-
Evaluation of pre-radiotherapy cyclophosphamide in patients with newly diagnosed glioblastoma multiforme. Writing Committee for The Brain Tumor Center at Duke.J Neurooncol. 2000;46(2):151-6. doi: 10.1023/a:1006258026274. J Neurooncol. 2000. PMID: 10894368 Clinical Trial.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Medical